Search Results - Daniel C. Gibbons

  • Showing 1 - 9 results of 9
Refine Results
  1. 1

    The increasing incidence and prevalence of hypereosinophilic syndrome in the United Kingdom by Gema Requena, John Logie, Daniel C. Gibbons, Jonathan Steinfeld, Melissa K. Van Dyke

    Published in Immunity, Inflammation and Disease (2021-12-01)
    Get full text
    Article


  2. 2

    Disease burden of primary biliary cholangitis and associated pruritus based on a cross-sectional US claims analysis by Helen Smith, Usha Gungabissoon, Daniel C Gibbons, Gema Requena, Andrea Ribeiro de Souza

    Published in BMJ Open Gastroenterology (2022-10-01)
    Get full text
    Article


  3. 3

    Characteristics and outcomes of COVID-19 patients presumed to be treated with sotrovimab in NHS hospitals in England by Vishal Patel, Bethany Levick, Stephen Boult, Daniel C. Gibbons, Myriam Drysdale, Emily J. Lloyd, Moushmi Singh, Helen J. Birch

    Published in BMC Infectious Diseases (2024-04-01)
    Get full text
    Article


  4. 4

    Treatment patterns, healthcare resource use, and costs associated with uncomplicated urinary tract infection among female patients in the United States. by Rena C Moon, Alen Marijam, Fanny S Mitrani-Gold, Daniel C Gibbons, Alex Kartashov, Ning A Rosenthal, Ashish V Joshi

    Published in PLoS ONE (2022-01-01)
    Get full text
    Article


  5. 5

    Characteristics and outcomes of patients with COVID-19 at high risk of disease progression receiving sotrovimab, oral antivirals, or no treatment: a retrospective cohort study by Myriam Drysdale, Holly Tibble, Vishal Patel, Daniel C. Gibbons, Emily J. Lloyd, William Kerr, Calum Macdonald, Helen J. Birch, Aziz Sheikh

    Published in BMC Infectious Diseases (2024-07-01)
    Get full text
    Article


  6. 6

    Real-World Effectiveness of Sotrovimab for the Early Treatment of COVID-19 During SARS-CoV-2 Delta and Omicron Waves in the USA by Mindy M. Cheng, Carolina Reyes, Sacha Satram, Helen Birch, Daniel C. Gibbons, Myriam Drysdale, Christopher F. Bell, Anvar Suyundikov, Xiao Ding, M. Cyrus Maher, Wendy Yeh, Amalio Telenti, Lawrence Corey

    Published in Infectious Diseases and Therapy (2023-01-01)
    Get full text
    Article


  7. 7

    Real-world effectiveness of sotrovimab in preventing hospitalization and mortality in high-risk patients with COVID-19 in the United States: A cohort study from the Mayo Clinic ele... by Christopher F Bell, Daniel C Gibbons, Myriam Drysdale, Helen J Birch, Emily J Lloyd, Vishal Patel, Corinne Carpenter, Katherine Carlson, Ediz S Calay, Arjun Puranik, Tyler E Wagner, John C O'Horo, Raymund R Razonable

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  8. 8

    Real-world effectiveness of sotrovimab in preventing hospitalization and mortality in high-risk patients with COVID-19 in the United States: A cohort study from the Mayo Clinic ele... by Christopher F. Bell, Daniel C. Gibbons, Myriam Drysdale, Helen J. Birch, Emily J. Lloyd, Vishal Patel, Corinne Carpenter, Katherine Carlson, Ediz S. Calay, Arjun Puranik, Tyler E. Wagner, John C. O’Horo, Raymund R. Razonable

    Published in PLoS ONE (2024-01-01)
    Get full text
    Article


  9. 9

    Comparative effectiveness of sotrovimab versus no treatment in non-hospitalised high-risk COVID-19 patients in north west London: a retrospective cohort study by Stephen J Brett, Vishal Patel, Sophie Young, Bethany Levick, Daniel C Gibbons, Tahereh Kamalati, Myriam Drysdale, Evgeniy R Galimov, Marcus James Yarwood, Jonathan D Watkins, Benjamin F Pierce, Emily J Lloyd, William Kerr, Helen J Birch

    Published in BMJ Open Respiratory Research (2024-07-01)
    Get full text
    Article


Search Tools: